Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neuronetics Inc STIM

Healthcare Medical Devices
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength... see more

Recent & Breaking News (NDAQ:STIM)

Neuronetics to Present at the Canaccord Genuity 41st Annual Growth Conference

GlobeNewswire July 29, 2021

Neuronetics to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call

GlobeNewswire July 20, 2021

Neuronetics Launches Enhanced Digital Resource Center for NeuroStar Providers

GlobeNewswire July 14, 2021

Neuronetics Set to Join Russell 2000® Index

GlobeNewswire June 23, 2021

Neuronetics Unveils New Clinical Data at Clinical TMS Society 2021 Annual Meeting

GlobeNewswire June 9, 2021

Neuronetics to Present at The JMP Securities Life Sciences Conference

GlobeNewswire June 3, 2021

Neuronetics Names Todd Cushman as Vice President, Business Development

GlobeNewswire June 1, 2021

Neuronetics to Present at the William Blair 41st Annual Growth Stock Conference

GlobeNewswire May 20, 2021

Neuronetics® Celebrates 100,000 Treatment Milestone for Southern California TMS Center

GlobeNewswire May 17, 2021

Neuronetics Employee Patient Advocates Honor Mental Health Awareness Month by Sharing Personal Depression Experiences

GlobeNewswire May 3, 2021

Neuronetics To Present Clinical Data at The American Psychiatric Association 2021 Annual Meeting

GlobeNewswire April 29, 2021

Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call

GlobeNewswire April 20, 2021

Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors

GlobeNewswire April 14, 2021

Neuronetics Announces Appointment of Robert Cascella to its Board of Directors

GlobeNewswire April 1, 2021

Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical

GlobeNewswire March 11, 2021

Neuronetics Enhances TrakStar® Cloud Patient Data Management System to Maximize Physician Efficiencies

GlobeNewswire March 9, 2021

Neuronetics Names Cory Anderson Vice President, Clinical Affairs and Medical Operations

GlobeNewswire March 3, 2021

Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

GlobeNewswire March 2, 2021

NeuroStar® Advanced Therapy Outcomes Registry Clinical Data Published in Brain Stimulation Validates Depression Treatment Protocols

GlobeNewswire February 23, 2021

Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call

GlobeNewswire February 16, 2021